Cargando…
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study
BACKGROUND: Magnetic resonance imaging (MRI) plays an important role in tumor detection/diagnosis. The use of exogenous contrast agents (CAs) helps to improve the discrimination between lesion and neighbouring tissue, but most of the currently available CAs are non-specific. Assessing the performanc...
Autores principales: | Candiota, Ana Paula, Acosta, Milena, Simões, Rui Vasco, Delgado-Goñi, Teresa, Lope-Piedrafita, Silvia, Irure, Ainhoa, Marradi, Marco, Bomati-Miguel, Oscar, Miguel-Sancho, Nuria, Abasolo, Ibane, Schwartz, Simó, Santamaria, Jesús, Penadés, Soledad, Arús, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021710/ https://www.ncbi.nlm.nih.gov/pubmed/24708566 http://dx.doi.org/10.1186/1477-3155-12-12 |
Ejemplares similares
-
Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment
por: Arias-Ramos, Nuria, et al.
Publicado: (2017) -
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives
por: Candiota, Ana Paula, et al.
Publicado: (2022) -
Metal-Free Radical Dendrimers as MRI Contrast Agents
for Glioblastoma Diagnosis: Ex Vivo and In
Vivo Approaches
por: Zhang, Songbai, et al.
Publicado: (2022) -
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs
por: Chiodo, Fabrizio, et al.
Publicado: (2014) -
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches
por: Wu, Shuang, et al.
Publicado: (2020)